TRWD Launches Media Campaign to Expand Brand Visibility Across North America and Latin America GlobeNewswire November 05, 2025 NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Tradewinds Universal, Inc. (OTC: TRWD), a publicly traded holding company expanding within the entertainment sector, announced today the launch of a global media campaign designed to increase shareholder value, […]

Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia GlobeNewswire November 05, 2025 TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Research Ethics Board (“REB”) has granted approval for

Nexalin Technology's Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer's Disease and Dementia This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin's frequency neurostimulator as a potential non-invasive therapy for cognitive disorders associated with Alzheimer's disease GlobeNewswire November 05, 2025 HOUSTON, TX, Nov.

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors GlobeNewswire November 05, 2025 Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or metastatic refractory solid tumors NRM-823

YD Bio and EG BioMed Expand U.S. Access to OkaiDx(TM), a cfDNAâ€'Methylation Blood Test for Postâ€'Treatment Breast Cancer Monitoring GlobeNewswire November 05, 2025 Taipei, Taiwan, Nov. 05, 2025 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced

Partners for Affordable Housing mobilizes socially-inspired capital to accelerate investment in affordable housing solutions New foundation brings governments, funders, non-profits, developers and community leaders together in new ways to address affordable housing at scale GlobeNewswire November 05, 2025 CALGARY, Alberta, Nov. 05, 2025 (GLOBE NEWSWIRE) — With Canada's affordable housing crisis at a breaking point,

Unwrap Unbeatable Deals This Season at Grocery Outlet, Your Xtreme Value(TM) Holiday Headquarters Save up to 60% on your holiday shopping with sales on wine, turkey and more at Grocery Outlet GlobeNewswire November 05, 2025 EMERYVILLE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet” or the “Company”) is

iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers Grand Opening Celebrates Expansion of Patient Access to Premium Medical Products, New Brands and Elevated Shopping Experience GlobeNewswire November 05, 2025 NEW YORK and TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF),

Snyk and Factory Partner to Secure AI-Native Development, Prioritizing Speed and Security Snyk Studio for Factory empowers Droids with automated vulnerability prevention and remediation GlobeNewswire November 05, 2025 BOSTON and SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Snyk, the AI security company, and Factory, the company bringing agent-native development to enterprises with specialized AI

Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 05, 2025 BRISBANE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today reported financial results for the quarter ended September 30, 2025